Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably…
Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably…
Frictionless operational reporting is crucial for enterprises aiming to monitor and improve business health through…
Jenzabar’s Cloud Enterprise Resource Planning (ERP) Software Selected for Its Student-Oriented Features and Ability to…
Highlights: Full year 2022 was a record year for both net sales and EBITDA, driven…
Initiated the global Phase 2 study of NTLA-2002, a CRISPR-based, potential single-dose treatment for hereditary…
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
CAMBRIDGESHIRE, United Kingdom, Feb. 21, 2023 (GLOBE NEWSWIRE) — LEX Diagnostics (LEX) today announces the…
WALTHAM, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2022 9 FEBRUARY 2023 at 12:00 EET Orion Group Financial Statement Release 2022…
MuleSoft Certified Connector for Trax simplifies integration to Salesforce Consumer Goods Cloud and helps CPG…
To accelerate growth and adapt to new business challenges, SATEBA intelligently connects an entire ecosystem…
Software will complement insightsoftware’s budgeting and planning solutions for enterprise customers who leverage Power BI…
CHICAGO–(BUSINESS WIRE)–Leading advisory CPA firm Baker Tilly US, LLP (Baker Tilly) announces the implementation and…
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today…
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today…
New visual brand unifies QAD’s growing product suite and signifies its position in the SaaS…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Fiscal 2023 Q1 net sales of $628 million Fiscal 2023 Q1 loss per share of…
Growth Catalyzed by Innovation Outsourcing in SecurityTech, FinTech, HealthTech and Enterprise Resource Planning OAK BROOK,…